Literature DB >> 3978799

Radioenzymic determination of homocysteine in plasma and urine.

H Refsum, S Helland, P M Ueland.   

Abstract

Using a modification of the radioenzymic assay described previously (J Biol Chem 259: 2360-2364, 1984) we measured homocysteine in freshly prepared plasma and urine from volunteers. The concentration of free homocysteine--i.e., the amount measurable in plasma after deproteinization by strong acid--was 2.27 (SEM 0.11) mumol/L for 18 men and 1.95 (SEM 0.13) mumol/L for 16 women (p greater than 0.05, not significant). About 70% of the total homocysteine in human plasma was associated with plasma proteins, and was precipitated with strong acid. The concentration of protein-bound homocysteine in plasma was 6.51 (SEM 0.32) mumol/L for men and 7.29 (SEM 0.65) mumol/L for women, a significantly (p less than 0.01) different spread. Homocysteine was rapidly released from plasma proteins in the presence of a reducing agent, dithioerythritol. By gel filtration of plasma on a "high-performance" liquid-chromatographic column, albumin was shown to be the sole carrier of homocysteine in plasma. Because the fraction bound to protein as determined by this procedure equaled that obtained by precipitation of plasma proteins with acid, we conclude that homocysteine is bound to albumin in vivo. The concentration of homocysteine in urine ranged from 3.5 to 9.5 mumol/L, about 6 mumol of homocysteine being excreted per 24 h.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978799

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  20 in total

Review 1.  The localization and interactions of huntingtin.

Authors:  A L Jones
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 2.  Hyperhomocysteinaemia and associated disease.

Authors:  R C Bakker; D P Brandjes
Journal:  Pharm World Sci       Date:  1997-06

3.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

4.  Mathematical modeling of the methionine cycle and transsulfuration pathway in individuals with autism spectrum disorder.

Authors:  Troy Vargason; Daniel P Howsmon; Stepan Melnyk; S Jill James; Juergen Hahn
Journal:  J Theor Biol       Date:  2016-12-29       Impact factor: 2.691

5.  Homocysteine and cardiovascular disease: should we treat?

Authors:  Kathleen Potter
Journal:  Clin Biochem Rev       Date:  2008-02

Review 6.  Assessment of homocysteine status.

Authors:  H Refsum; T Fiskerstrand; A B Guttormsen; P M Ueland
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

7.  Homocysteine metabolism in children with idiopathic nephrotic syndrome.

Authors:  Mohan Kundal; Abhijeet Saha; N K Dubey; Kanika Kapoor; Trayambak Basak; Gaurav Bhardwaj; Vinay Singh Tanwar; Shantanu Sengupta; Vinita Batra; Ashish Dutt Upadhayay; Ajay Bhatt
Journal:  Clin Transl Sci       Date:  2014-01-23       Impact factor: 4.689

Review 8.  Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease.

Authors:  Alla V Glushchenko; Donald W Jacobsen
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

9.  Homocystamides promote free-radical and oxidative damage to proteins.

Authors:  Martha Sibrian-Vazquez; Jorge O Escobedo; Soojin Lim; George K Samoei; Robert M Strongin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-18       Impact factor: 11.205

10.  Effect of methotrexate on homocysteine and other sulfur compounds in tissues of rats fed a normal or a defined, choline-deficient diet.

Authors:  A M Svardal; P M Ueland; R K Berge; A Aarsland; N Aarsaether; P E Lønning; H Refsum
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.